BioCentury
ARTICLE | Management Tracks

Larson leaving LianBio as CFO

Plus: Claypoole becomes CEO of Bioventus, and updates from Boston Pharma, Atlas, Quest, Scribe, 858 and more

December 21, 2023 1:48 AM UTC

LianBio (NASDAQ:LIAN) said Wednesday that it has named VP, Head of Global Finance Ehong “Maggie” Gu interim CFO following the resignation of CFO Yi Larson on Dec. 19. CEO Yizhe Wang resigned on the same day. Adam Stone, chief investment officer of Perceptive Advisors and a member of LianBio’s board, is now interim CEO of the cross-border biopharma.

Bioventus Inc. (NASDAQ:BVS) named Robert Claypoole as president, CEO and a director, effective Jan. 10. Claypoole, who succeeds interim CEO Anthony Bihl, was most recently EVP at Mölnlycke Health Care AB, where he led the company’s wound care business...